Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 5,335,750 | 4,230,045 | 3,026,139 | 2,028,400 | 1,324,621 |
| Cost of Goods | 1,127,246 | 768,771 | 433,320 | 260,326 | 166,587 |
| Gross Profit | 4,208,504 | 3,461,274 | 2,592,819 | 1,768,074 | 1,158,034 |
| Operating Expenses | 1,530,209 | 1,297,538 | 3,351,892 | 659,333 | 531,234 |
| Operating Income | 2,678,541 | 2,164,507 | -758,753 | 1,109,067 | 627,387 |
| Interest Expense | 65,244 | 63,181 | 20,362 | 442 | 7,345 |
| Other Income | 59,401 | 109,823 | 140,908 | 53,167 | 36,380 |
| Pre-tax Income | 2,672,698 | 2,211,149 | -638,207 | 1,161,792 | 656,422 |
| Income Tax | 702,363 | 635,355 | 551,750 | 347,878 | 207,051 |
| Net Income Continuous | 1,970,335 | 1,575,794 | -1,189,957 | 813,914 | 449,371 |
| Minority Interests | -8,564 | -9,108 | N/A | N/A | N/A |
| Net Income | $1,978,899 | $1,584,902 | $-1,189,957 | $813,914 | $449,371 |
| EPS Basic Total Ops | 1.08 | 0.86 | -0.65 | 0.45 | 0.26 |
| EPS Basic Continuous Ops | 1.07 | 0.85 | -0.65 | 0.45 | 0.26 |
| EPS Diluted Total Ops | 1.03 | 0.82 | -0.65 | 0.43 | 0.25 |
| EPS Diluted Continuous Ops | 1.03 | 0.82 | -0.65 | 0.43 | 0.24 |
| EBITDA(a) | $2,834,151 | $2,265,867 | $-711,469 | $1,144,844 | $651,795 |